Subscribe to Newsletter

Ben Pellegrini

CEO and co-founder of Intellegens, a machine learning (ML) software company, focused on research-intensive industries such as chemicals, life sciences, and materials. Originally a spinout from the University of Cambridge, Intellegens worked alongside automotive giant Rolls Royce in a research project to extract more value from rare experimental and process data to optimize the design of a new superalloy.

Content by Ben Pellegrini:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register